FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2049472332> ?p ?o ?g. }

• W2049472332 endingPage "2044" @default.
• W2049472332 startingPage "2035" @default.
• W2049472332 abstract "Inflammation and tissue degeneration play key roles in numerous rheumatic diseases, including osteoarthritis (OA). Efforts to reduce and effectively repair articular cartilage damage in an osteoarthritic environment are limited in their success due to the diseased environment. Treatment strategies focused on both reducing inflammation and increasing tissue production are necessary to effectively treat OA from a tissue-engineering perspective. In this work, we investigated the anti-inflammatory and tissue production capacity of a small molecule 3,4,6-O-tributanoylated-N-acetylglucosamine (3,4,6-O-Bu3GlcNAc) previously shown to inhibit the nuclear factor κB (NFκB) activity, a key transcription factor regulating inflammation. To mimic an inflammatory environment, chondrocytes were stimulated with interleukin-1β (IL-1β), a potent inflammatory cytokine. 3,4,6-O-Bu3GlcNAc exposure decreased the expression of NFκB target genes relevant to OA by IL-1β-stimulated chondrocytes after 24 h of exposure. The capacity of 3,4,6-O-Bu3GlcNAc to stimulate extracellular matrix (ECM) accumulation by IL-1β-stimulated chondrocytes was evaluated in vitro utilizing a three-dimensional hydrogel culturing system. After 21 days, 3,4,6-O-Bu3GlcNAc exposure induced quantifiable increases in both sulfated glycosaminoglycan and total collagen. Histological staining for proteoglycans and type II collagen confirmed these findings. The increased ECM accumulation was not due to the hydrolysis products of the small molecule, n-butyrate and N-acetylglucosamine (GlcNAc), as the isomeric 1,3,4-O-tributanoylated N-acetylglucosamine (1,3,4-O-Bu3GlcNAc) did not elicit a similar response. These findings demonstrate that a novel butanoylated GlcNAc derivative, 3,4,6-O-Bu3GlcNAc, has the potential to stimulate new tissue production and reduce inflammation in IL-1β-induced chondrocytes with utility for OA and other forms of inflammatory arthritis." @default.
• W2049472332 created "2016-06-24" @default.
• W2049472332 creator A5012140272 @default.
• W2049472332 creator A5017494930 @default.
• W2049472332 creator A5022442505 @default.
• W2049472332 creator A5038164189 @default.
• W2049472332 creator A5063641495 @default.
• W2049472332 creator A5067156333 @default.
• W2049472332 creator A5078551090 @default.
• W2049472332 creator A5088474684 @default.
• W2049472332 date "2013-09-01" @default.
• W2049472332 modified "2023-09-25" @default.
• W2049472332 title "Short-Chain Fatty Acid-Modified Hexosamine for Tissue-Engineering Osteoarthritic Cartilage" @default.
• W2049472332 cites W1494793657 @default.
• W2049472332 cites W1678513801 @default.
• W2049472332 cites W1852417086 @default.
• W2049472332 cites W1993228795 @default.
• W2049472332 cites W2001705900 @default.
• W2049472332 cites W2007719003 @default.
• W2049472332 cites W2008368193 @default.
• W2049472332 cites W2010782200 @default.
• W2049472332 cites W2018371082 @default.
• W2049472332 cites W2027648652 @default.
• W2049472332 cites W2028318172 @default.
• W2049472332 cites W2032255522 @default.
• W2049472332 cites W2033381870 @default.
• W2049472332 cites W2034462747 @default.
• W2049472332 cites W2035469813 @default.
• W2049472332 cites W2044573254 @default.
• W2049472332 cites W2052535861 @default.
• W2049472332 cites W2061062422 @default.
• W2049472332 cites W2061244880 @default.
• W2049472332 cites W2062563149 @default.
• W2049472332 cites W2071098571 @default.
• W2049472332 cites W2075713519 @default.
• W2049472332 cites W2081899896 @default.
• W2049472332 cites W2088181163 @default.
• W2049472332 cites W2107277218 @default.
• W2049472332 cites W2116350182 @default.
• W2049472332 cites W2127679013 @default.
• W2049472332 cites W2132865989 @default.
• W2049472332 cites W2133915381 @default.
• W2049472332 cites W2141363952 @default.
• W2049472332 cites W2148711700 @default.
• W2049472332 cites W2159542600 @default.
• W2049472332 cites W2162035907 @default.
• W2049472332 cites W2164880987 @default.
• W2049472332 cites W2820530002 @default.
• W2049472332 cites W2999065750 @default.
• W2049472332 cites W4241160583 @default.
• W2049472332 cites W4379365691 @default.
• W2049472332 doi "https://doi.org/10.1089/ten.tea.2012.0317" @default.
• W2049472332 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3725939" @default.
• W2049472332 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23638885" @default.
• W2049472332 hasPublicationYear "2013" @default.
• W2049472332 type Work @default.
• W2049472332 sameAs 2049472332 @default.
• W2049472332 citedByCount "13" @default.
• W2049472332 countsByYear W20494723322014 @default.
• W2049472332 countsByYear W20494723322015 @default.
• W2049472332 countsByYear W20494723322016 @default.
• W2049472332 countsByYear W20494723322017 @default.
• W2049472332 countsByYear W20494723322019 @default.
• W2049472332 countsByYear W20494723322021 @default.
• W2049472332 countsByYear W20494723322022 @default.
• W2049472332 countsByYear W20494723322023 @default.
• W2049472332 crossrefType "journal-article" @default.
• W2049472332 hasAuthorship W2049472332A5012140272 @default.
• W2049472332 hasAuthorship W2049472332A5017494930 @default.
• W2049472332 hasAuthorship W2049472332A5022442505 @default.
• W2049472332 hasAuthorship W2049472332A5038164189 @default.
• W2049472332 hasAuthorship W2049472332A5063641495 @default.
• W2049472332 hasAuthorship W2049472332A5067156333 @default.
• W2049472332 hasAuthorship W2049472332A5078551090 @default.
• W2049472332 hasAuthorship W2049472332A5088474684 @default.
• W2049472332 hasBestOaLocation W20494723322 @default.
• W2049472332 hasConcept C105702510 @default.
• W2049472332 hasConcept C109523444 @default.
• W2049472332 hasConcept C136229726 @default.
• W2049472332 hasConcept C142724271 @default.
• W2049472332 hasConcept C153074725 @default.
• W2049472332 hasConcept C185592680 @default.
• W2049472332 hasConcept C189165786 @default.
• W2049472332 hasConcept C203014093 @default.
• W2049472332 hasConcept C204787440 @default.
• W2049472332 hasConcept C2776164576 @default.
• W2049472332 hasConcept C2776914184 @default.
• W2049472332 hasConcept C2779335624 @default.
• W2049472332 hasConcept C2780550940 @default.
• W2049472332 hasConcept C49892992 @default.
• W2049472332 hasConcept C55493867 @default.
• W2049472332 hasConcept C71924100 @default.
• W2049472332 hasConcept C86803240 @default.
• W2049472332 hasConcept C95444343 @default.
• W2049472332 hasConceptScore W2049472332C105702510 @default.
• W2049472332 hasConceptScore W2049472332C109523444 @default.
• W2049472332 hasConceptScore W2049472332C136229726 @default.
• W2049472332 hasConceptScore W2049472332C142724271 @default.

• next